Quantification of the serotonin 1A receptor using PET: Identification of a potential biomarker of major depression in males

Neuropsychopharmacology

Volumn 40, Issue 7, 2015, Pages 1692-1699

  Kaufman, Joshua ^a   Sullivan, Gregory M ^b   Yang, Jie ^a   Ogden, R Todd ^c   Miller, Jeffrey M ^b   Oquendo, Maria A ^b   Mann, J John ^b   Parsey, Ramin V ^a   DeLorenzo, Christine ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b Columbia University College of Physicians ^*  (United States)

^c Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; N-(2-(4-(2-METHOXYPHENYL)-1-PIPERAZINYL)ETHYL)-N-(2-PYRIDINYL)CYCLOHEXANECARBOXAMIDE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN 1A RECEPTOR; SEROTONIN ANTAGONIST;

ADOLESCENT; ADULT; AGED; DIAGNOSTIC IMAGING; GENETICS; GENOTYPE; HUMAN; MAJOR DEPRESSION; MALE; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RAPHE NUCLEUS; SEXUAL DEVELOPMENT; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CARBON ISOTOPES; DEPRESSIVE DISORDER, MAJOR; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PYRIDINES; RAPHE NUCLEI; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN ANTAGONISTS; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84939979417     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.15     Document Type: Article

References (50)

1. Arango V, Underwood MD, Boldrini M, Tamir H, Kassir SA, Hsiung S et al (2001). Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 25: 892-903.
2. Bhagwagar Z, Rabiner EA, Sargent PA, Grasby PM, Cowen PJ (2004). Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol Psychiatry 9: 386-392.
3. Birzniece V, Johansson IM, Wang MD, Seckl JR, Backstrom T, Olsson T (2001). Serotonin 5-HT(1A) receptor mRNA expression in dorsal hippocampus and raphe nuclei after gonadal hormone manipulation in female rats. Neuroendocrinology 74: 135-142.
4. Blier P, Pineyro G, el Mansari M, Bergeron R, de Montigny C (1998). Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Ann N Y Acad Sci 861: 204-216.
5. Boldrini M, Underwood MD, Mann JJ, Arango V (2008). Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. J Psychiatr Res 42: 433-442.
6. Castro M, Diaz A, del Olmo E, Pazos A (2003). Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain. Neuropharmacology 44: 93-101.
7. Flugge G, Pfender D, Rudolph S, Jarry H, Fuchs E (1999). 5HT1Areceptor binding in the brain of cyclic and ovariectomized female rats. J Neuroendocrinol 11: 243-249.
8. Frankfurt M, McKittrick CR, Mendelson SD, McEwen BS (1994). Effect of 5,7-dihydroxytryptamine, ovariectomy and gonadal steroids on serotonin receptor binding in rat brain. Neuroendocrinology 59: 245-250.
9. Frey BN, Skelin I, Sakai Y, Nishikawa M, Diksic M (2010). Gender differences in alpha-[(11)C]MTrp brain trapping, an index of serotonin synthesis, in medication-free individuals with major depressive disorder: a positron emission tomography study. Psychiatry Res 183: 157-166.
10. Gottfries CG, Roos BE, Winblad B (1974). Determination of 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and homovanillic acid in brain tissue from an autopsy material. Acta Psychiatr Scand 50: 496-507.
11. Hesselgrave N, Parsey RV (2013). Imaging the serotonin 1A receptor using [11C]WAY100635 in healthy controls and major depression. Philos Trans R Soc Lond B Biol Sci 368: 20120004.
12. Hierholzer R (2006). Remission rates for depression in STAR∗D study. Am J Psychiatry 163: 1293; author reply 1293-1294.
13. Huang YY, Battistuzzi C, Oquendo MA, Harkavy-Friedman J, Greenhill L, Zalsman G et al (2004). Human 5-HT1A receptor C(-1019)G polymorphism and psychopathology. Int J Neuropsychopharmacol 7: 441-451.
14. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN et al (2007). Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27: 1533-1539.
15. Insel TR (2009). Disruptive insights in psychiatry: transforming a clinical discipline. J Clin Invest 119: 700-705.
16. Jovanovic H, Lundberg J, Karlsson P, Cerin A, Saijo T, Varrone A et al (2008). Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. NeuroImage 39: 1408-1419.
17. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR et al (2003). The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289: 3095-3105.
18. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB (1993). Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord 29: 85-96.
19. Kishi T, Yoshimura R, Fukuo Y, Okochi T, Matsunaga S, Umene-Nakano W et al (2013). The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended metaanalysis of patients with major depression and bipolar disorder. Eur Arch Psychiatry Clin Neurosci 263: 105-118.
20. Le Poul E, Boni C, Hanoun N, Laporte AM, Laaris N, Chauveau J et al (2000). Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 39: 110-122.
21. Martin LA, Neighbors HW, Griffith DM (2013). The experience of symptoms of depression in men vs women: analysis of the National Comorbidity Survey Replication. JAMA Psychiatry 70: 1100-1106.
22. Maswood S, Stewart G, Uphouse L (1995). Gender and oestrus cycle effects of the 5-HT1A agonist 8-OH-DPAT on hypothalamic serotonin. Pharmacol Biochem Behav 51: 807-813.
23. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M et al (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 64: 543-552.
24. Milak MS, DeLorenzo C, Zanderigo F, Prabhakaran J, Kumar JS, Majo VJ et al (2010). In vivo quantification of human serotonin 1A receptor using 11C-CUMI-101, an agonist PET radiotracer. J Nucl Med 51: 1892-1900.
25. Miller JM, Brennan KG, Ogden TR, Oquendo MA, Sullivan GM, Mann JJ et al (2009). Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality. Neuropsychopharmacology 34: 2275-2284.
26. Miller JM, Hesselgrave N, Ogden RT, Zanderigo F, Oquendo MA, Mann JJ et al (2013). Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder. Biol Psychiatry 74: 760-767.
27. Nishi K, Kanemaru K, Diksic M (2009). A genetic rat model of depression, Flinders sensitive line, has a lower density of 5-HT(1A) receptors, but a higher density of 5-HT(1B) receptors, compared to control rats. Neurochem Int 54: 299-307.
28. Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C et al (1997). Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA 94: 5308-5313.
29. Ogden RT, Tarpey T (2006). Estimation in regression models with externally estimated parameters. Biostatistics 7: 115-129.
30. Palucha A, Pilc A (2007). Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs. Pharmacol Ther 115: 116-147.
31. Parsey RV, Ogden RT, Miller JM, Tin A, Hesselgrave N, Goldstein E et al (2010). Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations. Biol Psychiatry 68: 170-178.
32. Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson N, Huang YY et al (2006). Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry 59: 106-113.
33. Parsey RV, Oquendo MA, Simpson NR, Ogden RT, Van Heertum R, Arango V et al (2002). Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res 954: 173-182.
34. Pecins-Thompson M, Bethea CL (1999). Ovarian steroid regulation of serotonin-1A autoreceptor messenger RNA expression in the dorsal raphe of rhesus macaques. Neuroscience 89: 267-277.
35. Peterson BS, Weissman MM (2011). A brain-based endophenotype for major depressive disorder. Annu Rev Med 62: 461-474.
36. Robichaud M, Debonnel G (2005). Oestrogen and testosterone modulate the firing activity of dorsal raphe nucleus serotonergic neurones in both male and female rats. J Neuroendocrinol 17: 179-185.
37. Rosecrans JA (1970). Differences in brain area 5-hydroxytryptamine turnover and rearing behavior in rats and mice of both sexes. Eur J Pharmacol 9: 379-382.
38. Sakai Y, Nishikawa M, Leyton M, Benkelfat C, Young SN, Diksic M (2006). Cortical trapping of alpha-[(11)C]methyl-l-tryptophan, an index of serotonin synthesis, is lower in females than males. NeuroImage 33: 815-824.
39. Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, Meyer J et al (2000). Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 57: 174-180.
40. Savitz J, Lucki I, Drevets WC (2009). 5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol 88: 17-31.
41. Savitz JB, Drevets WC (2013). Neuroreceptor imaging in depression. Neurobiol Dis 52: 49-65.
42. Singh I, Rose N (2009). Biomarkers in psychiatry. Nature 460: 202-207.
43. Stockmeier CA (2003). Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatric Res 37: 357-373.
44. Sullivan GM, Ogden RT, Oquendo MA, Kumar JS, Simpson N, Huang YY et al (2009). Positron emission tomography quantification of serotonin-1A receptor binding in medicationfree bipolar depression. Biol Psychiatry 66: 223-230.
45. Sullivan PF, Neale MC, Kendler KS (2000). Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 157: 1552-1562.
46. World Health Orangization (2004). Global Burden of Disease 2004 Update.
47. World Health Organization, Beaglehole R, Irwin A, Prentice T (2004). Annex Table 3: Burden of disease in DALYs by cause, sex, and mortality stratum in WHO regions, estimates for 2002. The world health report 2004: changing history. World Health Organization: Geneva, Vol xvii, 169 p.
48. Wu S, Comings DE (1999). A common C-1018G polymorphism in the human 5-HT1A receptor gene. Psychiatr Genet 9: 105-106.
49. Zhang L, Ma W, Barker JL, Rubinow DR (1999). Sex differences in expression of serotonin receptors (subtypes 1A and 2A) in rat brain: a possible role of testosterone. Neuroscience 94: 251-259.
50. Zhang ZJ, Wang D, Man SC, Ng R, McAlonan GM, Wong HK et al (2014). Platelet 5-HT receptor correlates with major depressive disorder in drug-free patients. Prog Neuropsychopharmacol Biol Psychiatry 53C: 74-79.